Overview
Ravi Patel is a Hematologist and an Oncologist in Grapevine, Texas. Dr. Patel has been practicing medicine for over 14 years and is rated as an Experienced provider by MediFind in the treatment of Anemia. His top areas of expertise are Myelodysplastic Syndrome (MDS), Breast Cancer, Mediastinal Tumor, and Merkel Cell Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- POS
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1631 Lancaster Drive, Suite 150, Grapevine, TX 76051
Alecia Nero is a Hematologist and a Pediatrics provider in Dallas, Texas. Dr. Nero is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Aspiration.
Texas Oncology, P.A.
Ashwani Agarwal is an Oncologist in Dallas, Texas. Dr. Agarwal has been practicing medicine for over 42 years and is rated as a Distinguished provider by MediFind in the treatment of Anemia. His top areas of expertise are Familial Colorectal Cancer, Anemia, Colorectal Cancer, and Childhood Iron Deficiency Anemia.
Texas Oncology PA
Jagathi Challagalla is a Hematologist Oncology specialist and an Oncologist in Dallas, Texas. Dr. Challagalla is rated as a Distinguished provider by MediFind in the treatment of Anemia. Her top areas of expertise are Paget Disease of the Breast, Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, and Inflammatory Breast Cancer. Dr. Challagalla is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Patel isAdvanced. Learn about Breast Cancer.
- Iron Deficiency AnemiaDr. Patel isAdvanced. Learn about Iron Deficiency Anemia.
- Mediastinal TumorDr. Patel isAdvanced. Learn about Mediastinal Tumor.
- Merkel Cell CarcinomaDr. Patel isAdvanced. Learn about Merkel Cell Carcinoma.
- Myelodysplastic Syndrome (MDS)Dr. Patel isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Mountain SicknessDr. Patel isExperienced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Patel isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Anal CancerDr. Patel isExperienced. Learn about Anal Cancer.
- AnemiaDr. Patel isExperienced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Patel isExperienced. Learn about Childhood Iron Deficiency Anemia.
- Chromophobe Renal Cell CarcinomaDr. Patel isExperienced. Learn about Chromophobe Renal Cell Carcinoma.